Taken together, our results support that modest mobilization of CSE, and “shedding” into serum, as well as a very significant reduction in circulating CBS (and MST), may indicate a signature pattern of sulfide dysregulation in MS. This evidence concerns the gene CTH and myeloid sarcoma.